RESPeRATE is based on Indian Yogic Principles of Pranayama. It is the first and only medical device cleared by the US FDA for adjunctive treatment of hypertension .
Nicholas Piramal India Limited (NPIL), one of India's leading pharmaceutical companies, today launched a revolutionary product, ‘RESPeRATE’, aimed at the management of hypertension. RESPeRATE is a patented product, developed on the yogic principles of Pranayama. It is the first and only medical device cleared by the US FDA for adjunctive treatment of hypertension.
RESPeRATE is a portable electronic device that helps lower blood pressure naturally by enabling the patient to quickly harness the power of paced breathing. Scientific evidence has shown that paced breathing, if done effortlessly, can lower blood pressure significantly by relaxing the muscles surrounding constricted blood vessels. It is the only medical device for high blood pressure treatment using patented Interactive Respiratory Pacing technology.
Benefits offered by RESPeRATE:
A proven, effective, non-drug approach to lowering high blood pressure 14/8 mm Hg average BP reduction within 8 weeks No side effects, no drug interactions, pleasant to use Well supported with clinical trials RESPeRATE is available in India directly from Nicholas Piramal India Ltd., (contact – 022-30466543, email@example.com)
RESPeRATE is manufactured by Intercure Ltd. – an Israeli company founded in 1997 that is headquartered in Fort Lee, New Jersey.